Big Pharma -

Key drugs driving recent revenue include semaglutide (Ozempic/Wegovy) from Novo Nordisk and various high-cost therapies for chronic conditions. Current Pricing and Regulatory Trends

The sector is dominated by a small group of multinational corporations. Big Pharma

Eli Lilly, Johnson & Johnson, AbbVie, and Roche are among the largest global players. Johnson & Johnson